Mick Lautt’s Post

View profile for Mick Lautt, graphic

CEO SciMar Ltd.

🎙️ I Had an enriching discussion on the CanadianSME Small Business Magazine Podcast, delving deep into the remarkable journey of SciMar Ltd.! 💼 In this episode, we explored the genesis of SciMar as a bio-research company with the mission to revolutionize the treatment landscape for type 2 diabetes worldwide. From our humble beginnings to securing over $19 million in investments and navigating the intricate terrain of the biotech industry, we covered it all. Key Highlights: 🔍 Entrepreneurial Genesis: Reflecting on the inception of SciMar and its noble mission to combat type 2 diabetes. 🔬 Scientific Breakthrough: A closer look at the groundbreaking science behind SciMar, particularly the pivotal role of hepatalin in diabetes management, and the response from the scientific community. 🚀 Navigating Challenges: Insights into the hurdles faced by SMEs in an arena largely dominated by big pharma and the strategies we've employed to carve our niche. ⏳ Path to Public Availability: Shedding light on the intricate process and timeline involved in making SciMar's innovative diabetes treatment accessible to the public. 💰 Innovative Funding Strategies: Discussing the significance of local investment and the transformative impact of Regulation A+ on SciMar's funding approach. Enjoyed the conversation? Feel free to reach out if you have any questions or are interested in investing in our groundbreaking venture. Link to the podcast below. Cheers! https://lnkd.in/gNtbNJmR

Breaking New Ground in Diabetes Research with Mick Lautt

Breaking New Ground in Diabetes Research with Mick Lautt

https://simplecast.com

To view or add a comment, sign in

Explore topics